The Gross Law Firm Encourages aTyr Shareholders to Make Claims by December 2025 Deadline

Attention aTyr Pharma Shareholders: Deadline Approaching for Class Action Participation

The Gross Law Firm has recently made an important announcement for the shareholders of aTyr Pharma, Inc. (NASDAQ: ATYR). If you've purchased shares in the company during their class action period from January 16, 2025, to September 12, 2025, now is a crucial moment to act. The deadline to register as a lead plaintiff in the upcoming case is set for December 8, 2025.

What’s the Case About?

This lawsuit centers around allegations that aTyr Pharma and its executives provided investors with misleading information regarding the efficacy of their drug, Efzofitimod. The core of the complaint states that while aTyr was publicly delivering overwhelmingly positive statements about this drug, they were also withholding significant adverse information, particularly regarding its ability to help patients completely taper off steroid use.

The situation escalated when aTyr hosted an investor call on September 15, 2025, announcing that their EFZO-FIT study had not achieved its primary endpoint, which sent shockwaves through the market. On this day, the company disclosed that they would engage with the FDA to assess the next steps following the disappointing results, which indicates the severity of the situation.

Stock Price Impact

Following the announcement, aTyr’s stock price suffered tremendously, plummeting from $6.03 per share on September 12, 2025, to just $1.02 on September 15, representing a staggering 83.2% drop in only one day. This significant loss highlights the potential impact that the misleading statements had on investors and the overall market.

Next Steps for Shareholders

For shareholders who want to be involved, it is essential to register as soon as possible to secure your position. Upon registration, you will receive updates via a portfolio monitoring software that will keep you informed throughout the litigation process. Participation in this case doesn’t come with any cost or obligation, which presents an opportunity for investors to seek redress for their losses due to the alleged misconduct.

To begin your registration, visit their official website to ensure your information is submitted correctly before the December deadline. The Gross Law Firm is committed to protecting investor rights and ensuring that corporate transparency is enforced, allowing shareholders to make informed decisions.

Why Choose The Gross Law Firm?

The Gross Law Firm has a national reputation for advocating for investors who have been victims of deceptive practices, fraud, or illegal activities conducted by their respective companies. They focus on holding firms accountable to ethical business standards and ensuring a rightful recovery for impacted shareholders.

With a strong dedication to defending investor interests, the firm provides a level of security for individuals navigating complex legal situations that arise within fast-paced markets.

For more details on how to register as a lead plaintiff, explore the official registration form available on the Gross Law Firm's website, or contact them directly via email or phone to clarify any doubts you may have about your eligibility.